Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
Yabe-Nishimura
C
C
Department of Pharmacology, Kyoto Prefectural University of Medicine, Japan.
D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D000074408:Aldo-Keto Reductases; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000201:enzymology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D008297:Male; D017434:Protein Structure, Tertiary; D012669:Seminal Vesicles / Q000187:drug effects / Q000502:physiology; D013379:Substrate Specificity
D004791:Enzyme Inhibitors; D000429:Alcohol Oxidoreductases; D000074408:Aldo-Keto Reductases; D000449:Aldehyde Reductase